SPARCC

Spondyloarthritis Research
Consortium of Canada

Who We Are

SPARCC is a group of rheumatologists and scientists who have come together to study spondyloarthritis. SPARCC is a national research program with a focus on genetic and pathogenesis studies and outcome measures for patients with spondyloarthritis. This will encompass studies in genetics to clinical epidemiology.

Known collectively as spondyloarthritis (SpA), this group of diseases is characterized by chronic inflammation of the pelvic joints and spine. It is frequently accompanied by arthritis in a number of other joints. SpA affects at least the same number of Canadians as rheumatoid arthritis (1 in 100 people). Until recently, SpA was under-recognized and under-studied in Canada.

Our Objectives are:

  1. An improved understanding of the biological basis of spondyloarthritis.
  2. Improved outcome measures to enhance stratification of disease severity, activity and progression.
  3. Improved assessment of the impact of spondyloarthritis in Canada with respect to special populations and age groups, and determinants of disability.

Current News & Events

2023 Canadian Spondylitis Association (CSA) & SPARCC Patient Forum

150 150 SPARCC
PATIENT FORUMS

The 2023 spondyloarthritis patient forum was held on November 21, 2023.

Axial-Spondyloarthritis Patient Forum – Recorded Webinar

Forum des patients atteints de spondylarthrite axiale – Webinaire enregistré

Pilot Projects – Seed Grants 2023

150 150 SPARCC
CALL FOR PILOT PROJECT GRANT SUBMISSIONS

CURRENT OPPORTUNITY

  • The SPARCC Research Pilot Project Program is open.
  • 1 Year $25,000 competition for innovative proposals
  • Project should align with SPARCC primary objective for the advancement of spondyloarthritis related research

Highlights in Research

Fatigue in Psoriatic Arthritis is an Important Factor for Patients

150 150 SPARCC

SPARCC published the results of an investigation into the relationship between fatigue and psychosocial factors in psoriatic arthritis. Using a combination of questionnaires and laboratory tests, the research team discovered that fatigue is a common symptom amongst these patients. Fatigue has strong connections with pain, physical functional disability, and psychological distress. Dr. Dafna Gladman comments: “This is an important discovery which will aid physicians caring for patients with psoriatic arthritis, since fatigue has a major impact of the quality of life for these patients. Such studies are beginning to make a real difference for our patients.”

Can You Catch Arthritis Like You Catch a Cold?

150 150 SPARCC

In 2005, 592 individuals in Ontario experienced food poisoning after consuming food products contaminated with Salmonella. SPARCC investigators found 53 individuals who developed arthritis after this episode of dysenteric outbreak. This provided important new information on the role of infection in the development of arthritis. The investigators then discovered that one particular gene (toll-like receptor 2) was associated with the type of arthritis that was developed. Dr. Robert Inman comments: “There has long been a suspicion about a role of infection as the cause of arthritis. With an outbreak of infection such as this, the opportunity arose to define what the interaction of genetics and infection might be which sets the stage of arthritis. This discovery has major implications for studying arthritis in populations exposed to common infectious diseases. It also suggests that new forms of treatment could be developed which are directed toward the interaction of the bacteria and this gene.

Privacy Preferences

When you visit our website, it may store information through your browser from specific services, usually in the form of cookies. Here you can change your Privacy preferences. It is worth noting that blocking some types of cookies may impact your experience on our website and the services we are able to offer.

Our website uses cookies, mainly from 3rd party services. Define your Privacy Preferences and/or agree to our use of cookies.